449 related articles for article (PubMed ID: 30890654)
1. Potential therapeutic targets for atherosclerosis in sphingolipid metabolism.
Yu Z; Peng Q; Huang Y
Clin Sci (Lond); 2019 Mar; 133(6):763-776. PubMed ID: 30890654
[TBL] [Abstract][Full Text] [Related]
2. Sphingolipid metabolism and atherosclerosis.
Jiang XC; Liu J
Handb Exp Pharmacol; 2013; (216):133-46. PubMed ID: 23563655
[TBL] [Abstract][Full Text] [Related]
3. Sphingolipids in Atherosclerosis: Chimeras in Structure and Function.
Peters L; Kuebler WM; Simmons S
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233252
[TBL] [Abstract][Full Text] [Related]
4. Gene expression of sphingolipid metabolism pathways is altered in hidradenitis suppurativa.
Dany M; Elston D
J Am Acad Dermatol; 2017 Aug; 77(2):268-273.e6. PubMed ID: 28551069
[TBL] [Abstract][Full Text] [Related]
5. Sphingolipids in psychiatric disorders and pain syndromes.
Mühle C; Reichel M; Gulbins E; Kornhuber J
Handb Exp Pharmacol; 2013; (216):431-56. PubMed ID: 23563670
[TBL] [Abstract][Full Text] [Related]
6. An overview of sphingolipid metabolism: from synthesis to breakdown.
Gault CR; Obeid LM; Hannun YA
Adv Exp Med Biol; 2010; 688():1-23. PubMed ID: 20919643
[TBL] [Abstract][Full Text] [Related]
7. Sphingolipid metabolizing enzymes as novel therapeutic targets.
Billich A; Baumruker T
Subcell Biochem; 2008; 49():487-522. PubMed ID: 18751924
[TBL] [Abstract][Full Text] [Related]
8. Effects of inhibitors of key enzymes of sphingolipid metabolism on insulin-induced glucose uptake and glycogen synthesis in liver cells of old rats.
Babenko NA; Kharchenko VS
Biochemistry (Mosc); 2015 Jan; 80(1):104-12. PubMed ID: 25754045
[TBL] [Abstract][Full Text] [Related]
9. Rewiring Endothelial Sphingolipid Metabolism to Favor S1P Over Ceramide Protects From Coronary Atherosclerosis.
Manzo OL; Nour J; Sasset L; Marino A; Rubinelli L; Palikhe S; Smimmo M; Hu Y; Bucci MR; Borczuk A; Elemento O; Freed JK; Norata GD; Di Lorenzo A
Circ Res; 2024 Apr; 134(8):990-1005. PubMed ID: 38456287
[TBL] [Abstract][Full Text] [Related]
10. Novel agents targeting bioactive sphingolipids for the treatment of cancer.
Adan-Gokbulut A; Kartal-Yandim M; Iskender G; Baran Y
Curr Med Chem; 2013; 20(1):108-22. PubMed ID: 23244584
[TBL] [Abstract][Full Text] [Related]
11. Druggable Sphingolipid Pathways: Experimental Models and Clinical Opportunities.
Blaho VA
Adv Exp Med Biol; 2020; 1274():101-135. PubMed ID: 32894509
[TBL] [Abstract][Full Text] [Related]
12. Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases.
Canals D; Perry DM; Jenkins RW; Hannun YA
Br J Pharmacol; 2011 Jun; 163(4):694-712. PubMed ID: 21615386
[TBL] [Abstract][Full Text] [Related]
13. Platelet extracellular vesicles mediate transfusion-related acute lung injury by imbalancing the sphingolipid rheostat.
McVey MJ; Weidenfeld S; Maishan M; Spring C; Kim M; Tabuchi A; Srbely V; Takabe-French A; Simmons S; Arenz C; Semple JW; Kuebler WM
Blood; 2021 Feb; 137(5):690-701. PubMed ID: 33232973
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of the sphingomyelin cycle: Sphingomyelin synthases and sphingomyelinases.
Adada M; Luberto C; Canals D
Chem Phys Lipids; 2016 May; 197():45-59. PubMed ID: 26200918
[TBL] [Abstract][Full Text] [Related]
15. Sphingolipid synthetic pathways are major regulators of lipid homeostasis.
Worgall TS
Adv Exp Med Biol; 2011; 721():139-48. PubMed ID: 21910087
[TBL] [Abstract][Full Text] [Related]
16. Emerging Roles of Ceramides in Breast Cancer Biology and Therapy.
Pal P; Atilla-Gokcumen GE; Frasor J
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232480
[TBL] [Abstract][Full Text] [Related]
17. Sphingolipids in neurodegeneration (with focus on ceramide and S1P).
Wang G; Bieberich E
Adv Biol Regul; 2018 Dec; 70():51-64. PubMed ID: 30287225
[TBL] [Abstract][Full Text] [Related]
18. Physiology and pathophysiology of sphingolipid metabolism and signaling.
Huwiler A; Kolter T; Pfeilschifter J; Sandhoff K
Biochim Biophys Acta; 2000 May; 1485(2-3):63-99. PubMed ID: 10832090
[No Abstract] [Full Text] [Related]
19. Differential regulation of sphingolipid metabolism in plasma, hippocampus, and cerebral cortex of mice administered sphingolipid modulating agents.
Giles C; Takechi R; Mellett NA; Meikle PJ; Dhaliwal S; Mamo JC
J Neurochem; 2017 May; 141(3):413-422. PubMed ID: 28129448
[TBL] [Abstract][Full Text] [Related]
20. Sphingolipids in the lungs.
Uhlig S; Gulbins E
Am J Respir Crit Care Med; 2008 Dec; 178(11):1100-14. PubMed ID: 18755926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]